Sentence examples for fmf in from inspiring English sources

Canakinumab was shown to be effective in treating pediatric patients with colchicine-resistant FMF in this study.

The prevalence of FMF in Armenia and in Karabakh, a region close to Armenia inhabited by Armenian people, is particularly high ranging from 0.5 to 1.5% [11].

We performed genotyping of the exon regions of the MEFV gene, which is thought to be a single genetic determinant of FMF, in particular exons 2 and 10, where the majority of disease-associated mutations were identified (http://fmf.igh.cnrs.fr/infevers).fr/infevers

Given the prevalence of FMF in Karabakh (∼0.01) and the frequency of the alpha/alpha genotype in this area (∼0.1), the expected percentage of Karabakhian alpha homozygous FMF patients is very low (at most 1.10−3); a negative selection could, therefore, easily pass unnoticed.

In addition, we described the clinical manifestations of FMF in 80 Japanese patients [ 14].

The first case of FMF in association with AS was described in 1963 [ 30].

We did not detect any substantial increase of systemic IgA levels in FMF patients in comparison with control subjects; in this regard, mucosal IgA seems an attractive target to study, especially in the light of its role in controlling the composition of gut microbiota [41].

(C) The Bush administration's commitment to provide Pakistan with $300 million annually in FMF expires in 2009, and we need to come to agreement with Pakistan on how to restructure its FMF program to meet its long-term COIN needs.

ISLAMABAD 00000236 005 OF 005 25. (C) The Bush administration commitment to provide Pakistan with $300 million annually in FMF expires in 2009, and we need to come to agreement with Pakistan on how to restructure its FMF program to meet its counter-insurgency needs.

At the phylotype level, the most diverse gut bacterial community was observed in FMF patients in remission.

The extrapolated curve confirmed the initial findings suggesting diminished diversity of gut bacteria in FMF attack in comparison with disease remission and control.